pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

FDA releases draft guidance on requirements for robotically assisted surgical devices

Sep 29, 2026·read at raps ↗RegulatoryNeutral

The FDA has published a draft guidance outlining its thinking on the requirements for bringing certain robotically assisted surgical devices to market.

The guidance describes both non-clinical and clinical testing that sponsors should incorporate into pre-market submissions.

The agency invites industry comments on the draft, indicating that the final guidance will shape future regulatory expectations for these technologies.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “FDA draft guidance addresses considerations for robotically assisted surgical devices”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoConvergence: Regulators highlight efforts to streamline the European regulatory frameworkraps
  • 1d agoRecon: FDA approves Egetis’ Emcitate for rare genetic disease; Novo buys rights to Chinese weight-loss pill in $2.6B dealraps
  • 2d agoRecon: FDA approves drugs for Parkinson’s, bile duct cancer, rare soft tissue disease; Merck, Daiichi scrap application for ADC ...raps
  • 2d agoAsia-Pacific Roundup: Indian government approves adverse event monitoring plan for transplantation productsraps
  • 2d agoConvergence: CBER expert offers tips for effective BLA submissionsraps